Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.

ABSTRACT:

Purpose

The COVID-19 vaccination campaign began in December 2020, in France, and primarily targeted the oldest people. Our study aimed to determine the level of acceptance of vaccination in a population of older patients with cancer.

Methods

From January 2021, we offered vaccination with the BNT162b2 COVID-19 vaccine to all patients 70 years and older referred to our geriatric oncology center in Marseille University Hospital (AP-HM) for geriatric assessment before initiation of an oncological treatment. Objectives were to evaluate acceptance rate of COVID-19 vaccination and to assess vaccine safety, reactogenicity, and efficacy two months after the first dose.

Results

Between January 18, 2021 and May 7, 2021, 150 older patients with cancer were offered vaccination aft

SUBMITTER: Couderc AL 

PROVIDER: S-EPMC9108027 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature